• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Mettler-Toledo International Inc. Reports First Quarter 2025 Results

    5/1/25 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $MTD alert in real time by email

    Mettler-Toledo International Inc. (NYSE:MTD) today announced first quarter results for 2025. Provided below are the highlights:

    • Reported sales declined 5% compared with the prior year. In local currency, sales decreased 3% compared with the prior year and grew 3% excluding the recovery of delayed shipments in the prior year.
    • Net earnings per diluted share as reported (EPS) were $7.81, compared with $8.24 in the prior-year period. Adjusted EPS was $8.19, a decrease of 8% over the prior-year amount of $8.89. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules.

    First Quarter Results

    Patrick Kaltenbach, President and Chief Executive Officer, stated, "We had a good start to the year with solid growth in our Laboratory business, excluding the recovery of delayed shipments in the first quarter of 2024. Strong execution of our margin expansion strategies led to better-than-expected earnings."

    GAAP Results

    EPS in the quarter was $7.81, compared with the prior-year amount of $8.24.

    Compared with the prior year, total reported sales declined 5% to $883.7 million. By region, reported sales decreased 2% in the Americas, 9% in Europe, and 4% in Asia/Rest of World. Earnings before taxes amounted to $201.9 million, compared with $220.5 million in the prior year.

    Non-GAAP Results

    Adjusted EPS was $8.19, a decrease of 8% over the prior-year amount of $8.89.

    Compared with the prior year, total sales in local currency decreased 3%. By region, local currency sales decreased 1% in the Americas, 7% in Europe, and 2% in Asia/Rest of World. Excluding the impact from delayed fourth quarter 2023 shipments that benefited first quarter 2024 results, sales in local currency increased 3%, including sales growth of 3% in the Americas, 4% in Europe, and 3% in Asia/Rest of World. Adjusted Operating Profit amounted to $236.7 million, compared with the prior-year amount of $267.3 million.

    Adjusted EPS and Adjusted Operating Profit are non-GAAP measures. Reconciliations to the most comparable GAAP measures are provided in the attached schedules.

    Outlook

    Management cautions that market conditions are uncertain and could change quickly. Based on today's assessment, management anticipates local currency sales for the second quarter of 2025 will increase approximately 0% to 1%. Adjusted EPS is forecast to be $9.45 to $9.70, a growth rate of down 2% to up 1%. Included in the second quarter guidance is an estimated 3% headwind to Adjusted EPS growth due to higher tariff costs net of our mitigating actions.

    For the full year 2025, management anticipates local currency sales will increase approximately 1% to 2%, which includes a headwind of approximately 1.5% from the previously disclosed shipping delays in the fourth quarter of 2023 that benefited the first quarter of 2024. Adjusted EPS is forecast to be in the range of $41.25 to $42.00, representing growth of approximately 0% to 2%. This forecast includes headwinds of approximately 4% from the previously mentioned shipping delays and an estimated 2% due to higher tariff costs net of our mitigating actions. This compares with previous local currency sales growth guidance of approximately 3% and Adjusted EPS guidance of $42.35 to $43.00.

    The Company does not provide GAAP financial measures on a forward-looking basis because we are unable to predict with reasonable certainty and without unreasonable effort the timing and amount of future restructuring and other non-recurring items.

    Conclusion

    Kaltenbach added, "The ongoing global trade disputes have significantly increased uncertainty in global customer demand. We also estimate gross incremental global tariff costs of approximately $115 million on an annualized basis and are implementing mitigating actions this year that will fully offset these costs next year. We are confident that our strong culture of operational excellence and our highly agile team will continue to perform well in this dynamic environment, and we will benefit from the breadth of our innovative product portfolio and strategic programs."

    Other Matters

    The Company will host a conference call to discuss its quarterly results tomorrow morning (Friday, May 2) at 8:30 a.m. Eastern Time. To listen to a live webcast or replay of the call, visit the investor relations page on the Company's website at investor.mt.com. The presentation referenced on the conference call will be located on the website prior to the call.

    METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes for customers in a wide range of industries including life sciences, food, and chemicals. Our sales and service network is one of the most extensive in the industry. Our products are sold in more than 140 countries and we have a direct presence in approximately 40 countries. With proven growth strategies and a focus on execution, we have achieved a long-term track record of strong financial performance. For more information, please visit www.mt.com.

    Forward-Looking Statements Disclaimer

    You should not rely on forward-looking statements to predict our actual results. Our actual results or performance may be materially different than reflected in forward-looking statements because of various risks and uncertainties, including statements about expected revenue growth, inflation, ongoing developments related to global trade disputes/tariffs, and the conflicts in Ukraine and the Middle East. You can identify forward-looking statements by terminology such as "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "potential," or "continue."

    We make forward-looking statements about future events or our future financial performance, including earnings and sales growth, earnings per share, strategic plans and contingency plans, growth opportunities or economic downturns, our ability to respond to changes in market conditions, planned research and development efforts and product introductions, adequacy of facilities, access to and the costs of raw materials, shipping and supplier costs, gross margins, customer demand, our competitive position, pricing, capital expenditures, cash flow, tax-related matters, the impact of foreign currencies, compliance with laws, effects of acquisitions, the impact of inflation, ongoing developments related to global trade disputes/tariffs, and the conflicts in Ukraine and the Middle East on our business.

    Our forward-looking statements may not be accurate or complete, and we do not intend to update or revise them in light of actual results. New risks also periodically arise. Please consider the risks and factors that could cause our results to differ materially from what is described in our forward-looking statements, including ongoing developments related to global trade disputes/tariffs, inflation, and the ongoing conflicts in Ukraine and the Middle East. See in particular "Factors Affecting Our Future Operating Results" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10-K for the year ended December 31, 2024 and other reports filed with the SEC from time to time.

    METTLER-TOLEDO INTERNATIONAL INC.
    CONSOLIDATED STATEMENTS OF OPERATIONS
    (amounts in thousands except share data)
    (unaudited)
     

    Three months ended

     

     

     

    Three months ended

     

     

    March 31, 2025

     

    % of sales

     

    March 31, 2024

     

    % of sales

     
    Net sales

    $

    883,744

     

    (a)

    100.0

     

    $

    925,949

     

    (a)

    100.0

    Cost of sales

     

    357,865

     

    40.5

     

     

    377,816

     

    40.8

     

    Gross profit

     

    525,879

     

    59.5

     

     

    548,133

     

    59.2

     

     
    Research and development

     

    46,346

     

    5.2

     

     

    46,415

     

    5.0

     

    Selling, general and administrative

     

    242,799

     

    27.5

     

     

    234,390

     

    25.3

     

    Amortization

     

    17,193

     

    2.0

     

     

    18,228

     

    2.0

     

    Interest expense

     

    16,653

     

    1.9

     

     

    19,232

     

    2.1

     

    Restructuring charges

     

    3,767

     

    0.4

     

     

    9,664

     

    1.0

     

    Other charges (income), net

     

    (2,821

    )

    (0.3

    )

     

    (343

    )

    -

     

    Earnings before taxes

     

    201,942

     

    22.8

     

     

    220,547

     

    23.8

     

     
    Provision for taxes

     

    38,355

     

    4.3

     

     

    43,038

     

    4.6

     

    Net earnings

    $

    163,587

     

    18.5

     

    $

    177,509

     

    19.2

     

     
    Basic earnings per common share:
    Net earnings

    $

    7.84

     

    $

    8.28

     

    Weighted average number of common shares

     

    20,868,873

     

     

    21,437,673

     

     
    Diluted earnings per common share:
    Net earnings

    $

    7.81

     

    $

    8.24

     

    Weighted average number of common

     

    20,945,188

     

     

    21,543,313

     

    and common equivalent shares
     
    Note:

    (a) Local currency sales decreased 3% as compared to the same period in 2024.

     
    RECONCILIATION OF EARNINGS BEFORE TAXES TO ADJUSTED OPERATING PROFIT
     

    Three months ended

     

     

     

    Three months ended

     

     

    March 31, 2025

     

    % of sales

     

    March 31, 2024

     

    % of sales

     
    Earnings before taxes

    $

    201,942

     

    $

    220,547

     

    Amortization

     

    17,193

     

     

    18,228

     

    Interest expense

     

    16,653

     

     

    19,232

     

    Restructuring charges

     

    3,767

     

     

    9,664

     

    Other charges (income), net

     

    (2,821

    )

     

    (343

    )

    Adjusted operating profit

    $

    236,734

     

    (b)

    26.8

     

    $

    267,328

     

    28.9

     

     
    Note:

    (b) Adjusted operating profit decreased 11% as compared to the same period in 2024.

    METTLER-TOLEDO INTERNATIONAL INC.

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (amounts in thousands)

    (unaudited)

     
    March 31, 2025 December 31, 2024
     
    Cash and cash equivalents

    $

    64,291

     

    $

    59,362

     

    Accounts receivable, net

     

    638,390

     

     

    687,112

     

    Inventories

     

    358,786

     

     

    342,274

     

    Other current assets and prepaid expenses

     

    103,328

     

     

    105,158

     

    Total current assets

     

    1,164,795

     

     

    1,193,906

     

     
    Property, plant and equipment, net

     

    778,004

     

     

    770,280

     

    Goodwill and other intangibles assets, net

     

    925,047

     

     

    926,057

     

    Other non-current assets

     

    366,833

     

     

    349,756

     

    Total assets

    $

    3,234,679

     

    $

    3,239,999

     

     
    Short-term borrowings and maturities of long-term debt

    $

    182,855

     

    $

    182,623

     

    Trade accounts payable

     

    201,423

     

     

    215,843

     

    Accrued and other current liabilities

     

    765,417

     

     

    769,727

     

    Total current liabilities

     

    1,149,695

     

     

    1,168,193

     

     
    Long-term debt

     

    1,891,240

     

     

    1,831,265

     

    Other non-current liabilities

     

    375,726

     

     

    367,431

     

    Total liabilities

     

    3,416,661

     

     

    3,366,889

     

     
    Shareholders' equity

     

    (181,982

    )

     

    (126,890

    )

    Total liabilities and shareholders' equity

    $

    3,234,679

     

    $

    3,239,999

     

    METTLER-TOLEDO INTERNATIONAL INC.
    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
    (amounts in thousands)
    (unaudited)
     

    Three months ended

    March 31,

    2025

     

    2024

     
    Cash flow from operating activities:
    Net earnings

    $

    163,587

     

    $

    177,509

     

    Adjustments to reconcile net earnings to
    net cash provided by operating activities:
    Depreciation

     

    12,464

     

     

    12,522

     

    Amortization

     

    17,193

     

     

    18,228

     

    Deferred tax provision (benefit)

     

    (879

    )

     

    (2,063

    )

    Share-based compensation

     

    5,139

     

     

    4,722

     

    Decrease in cash resulting from changes in
    operating assets and liabilities

     

    (3,055

    )

     

    (20,931

    )

    Net cash provided by operating activities

     

    194,449

     

     

    189,987

     

     
    Cash flows from investing activities:
    Purchase of property, plant and equipment

     

    (17,255

    )

     

    (17,391

    )

    Acquisitions

     

    -

     

     

    (1,000

    )

    Other investing activities

     

    10,348

     

     

    9,456

     

    Net cash used in investing activities

     

    (6,907

    )

     

    (8,935

    )

     
    Cash flows from financing activities:
    Proceeds from borrowings

     

    512,496

     

     

    449,863

     

    Repayments of borrowings

     

    (479,326

    )

     

    (418,280

    )

    Proceeds from exercise of stock options

     

    2,198

     

     

    1,831

     

    Repurchases of common stock

     

    (218,749

    )

     

    (212,499

    )

    Other financing activities

     

    (764

    )

     

    -

     

    Net cash used in financing activities

     

    (184,145

    )

     

    (179,085

    )

     
    Effect of exchange rate changes on cash and cash equivalents

     

    1,532

     

     

    (1,583

    )

     
    Net increase in cash and cash equivalents

     

    4,929

     

     

    384

     

     
    Cash and cash equivalents:
    Beginning of period

     

    59,362

     

     

    69,807

     

    End of period

    $

    64,291

     

    $

    70,191

     

     

    RECONCILIATION OF NET CASH PROVIDED BY OPERATING ACTIVITIES TO ADJUSTED FREE CASH FLOW

     

    Three months ended

    March 31,

    2025

     

    2024

     
    Net cash provided by operating activities

    $

    194,449

     

    $

    189,987

     

    Payments in respect of restructuring activities

     

    2,566

     

     

    9,714

     

    Purchase of property, plant and equipment, net

     

    (17,255

    )

     

    (17,391

    )

    Adjusted free cash flow

    $

    179,760

     

    $

    182,310

     

    METTLER-TOLEDO INTERNATIONAL INC.

    OTHER OPERATING STATISTICS
     
    SALES GROWTH BY DESTINATION
    (unaudited)
     

    Americas

    Europe

    Asia/RoW

    Total

     

     

     

     

    U.S. Dollar Sales Growth

     

     

     

     

    Three Months Ended March 31, 2025

    (2)%

    (9)%

    (4)%

    (5)%

     

     

     

     

    Local Currency Sales Growth

     

     

     

     

    Three Months Ended March 31, 2025

    (1)%

    (7)%

    (2)%

    (3)%

    Note:

    (a)

    The Company estimates net sales growth for the three months ended March 31, 2025 was reduced by approximately 6% from the recovery of delayed shipments during the first quarter of 2024. Excluding this impact, local currency net sales increased by 3%, and by geographic destination increased 3% in the Americas, 4% in Europe and 3% in Asia/Rest of World for the three months ended March 31, 2025.

    RECONCILIATION OF DILUTED EPS AS REPORTED TO ADJUSTED DILUTED EPS
    (unaudited)
     

    Three months ended

    March 31,

    2025

    2024

    % Growth

     
    EPS as reported, diluted

    $

    7.81

    $

    8.24

    (5

    %)

     
    Purchased intangible amortization, net of tax

     

    0.23

     

    (a)

     

    0.24

     

    (a)
    Restructuring charges, net of tax

     

    0.15

     

    (b)

     

    0.36

     

    (b)
    Income tax expense

     

    -

     

     

    0.05

     

    (c)
     
    Adjusted EPS, diluted

    $

    8.19

     

    $

    8.89

     

    (8

    %)

    Notes:

    (a)

    Represents the EPS impact of purchased intangibles amortization of $6.3 million ($4.9 million after tax) and $6.6 million ($5.1 million after tax) for the three month periods ended March 31, 2025 and 2024, respectively.

    (b)

    Represents the EPS impact of restructuring charges of $3.8 million ($3.1 million after tax) and $9.7 million ($7.8 million after tax) for the three months ended March 31, 2025 and 2024, respectively, which primarily include employee related costs.

    (c)

    Represents the EPS impact of the difference between our quarterly and estimated annual tax rate before non-recurring discrete items during the three months ended March 31, 2024 due to the timing of excess tax benefits associated with stock option exercises.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250501862342/en/

    Adam Uhlman

    Head of Investor Relations

    METTLER TOLEDO

    Direct: 614-438-4794

    [email protected]

    Get the next $MTD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MTD

    DatePrice TargetRatingAnalyst
    5/20/2025$1350.00Neutral → Buy
    UBS
    5/5/2025$1110.00Underperform → Hold
    Jefferies
    5/5/2025$1100.00Underperform → Hold
    Jefferies
    4/7/2025$1400.00Neutral → Buy
    Citigroup
    1/2/2025$1375.00 → $1450.00In-line → Outperform
    Evercore ISI
    12/13/2024Peer Perform
    Wolfe Research
    12/11/2024$1200.00 → $1300.00Sell → Neutral
    Citigroup
    8/28/2024$1400.00Equal Weight
    Wells Fargo
    More analyst ratings

    $MTD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Mettler-Toledo International Inc. Reports First Quarter 2025 Results

      Mettler-Toledo International Inc. (NYSE:MTD) today announced first quarter results for 2025. Provided below are the highlights: Reported sales declined 5% compared with the prior year. In local currency, sales decreased 3% compared with the prior year and grew 3% excluding the recovery of delayed shipments in the prior year. Net earnings per diluted share as reported (EPS) were $7.81, compared with $8.24 in the prior-year period. Adjusted EPS was $8.19, a decrease of 8% over the prior-year amount of $8.89. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. First Quarter Results Patrick Kaltenbach, President and Chie

      5/1/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. Announces Webcast of Presentation at the BofA Securities 2025 Healthcare Conference

      Mettler-Toledo International Inc. (NYSE:MTD) today announced it will present at the BofA Securities 2025 Healthcare Conference on Wednesday, May 14, 2025, at 4:20pm Pacific Time (7:20pm Eastern Time). A live webcast of the presentation will be available on the Company's investor relations website at investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes for customers in a wide

      4/25/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. to Host First Quarter 2025 Earnings Conference Call

      Mettler-Toledo International Inc. (NYSE:MTD) announced it will release its first quarter 2025 financial results after the market close on Thursday, May 1, 2025. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our s

      4/3/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    SEC Filings

    See more
    • SEC Form SD filed by Mettler-Toledo International Inc.

      SD - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

      5/30/25 8:39:40 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. filed SEC Form 8-K: Leadership Update

      8-K - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

      5/12/25 4:47:54 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

      5/6/25 11:25:47 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Mettler-Toledo upgraded by UBS with a new price target

      UBS upgraded Mettler-Toledo from Neutral to Buy and set a new price target of $1,350.00

      5/20/25 8:01:57 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo upgraded by Jefferies with a new price target

      Jefferies upgraded Mettler-Toledo from Underperform to Hold and set a new price target of $1,110.00

      5/5/25 8:42:51 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo upgraded by Jefferies with a new price target

      Jefferies upgraded Mettler-Toledo from Underperform to Hold and set a new price target of $1,100.00

      5/5/25 8:26:45 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Financials

    Live finance-specific insights

    See more
    • Mettler-Toledo International Inc. Reports First Quarter 2025 Results

      Mettler-Toledo International Inc. (NYSE:MTD) today announced first quarter results for 2025. Provided below are the highlights: Reported sales declined 5% compared with the prior year. In local currency, sales decreased 3% compared with the prior year and grew 3% excluding the recovery of delayed shipments in the prior year. Net earnings per diluted share as reported (EPS) were $7.81, compared with $8.24 in the prior-year period. Adjusted EPS was $8.19, a decrease of 8% over the prior-year amount of $8.89. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. First Quarter Results Patrick Kaltenbach, President and Chie

      5/1/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. to Host First Quarter 2025 Earnings Conference Call

      Mettler-Toledo International Inc. (NYSE:MTD) announced it will release its first quarter 2025 financial results after the market close on Thursday, May 1, 2025. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our s

      4/3/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. Reports Fourth Quarter 2024 Results

      Mettler-Toledo International Inc. (NYSE:MTD) today announced fourth quarter results for 2024. Provided below are the highlights: Reported and local currency sales increased 12% compared with the prior year. Net earnings per diluted share as reported (EPS) were $11.96, compared with $8.52 in the prior-year period. Adjusted EPS was $12.41, an increase of 32% over the prior-year amount of $9.40. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. Fourth Quarter Results Patrick Kaltenbach, President and Chief Executive Officer, stated, "We had a strong finish to the year as we capitalized on very good customer deman

      2/6/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

      SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

      2/13/24 5:09:38 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

      SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

      2/10/23 1:38:29 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

      SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

      2/10/22 5:03:51 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Kelly Michael A sold $1,231,846 worth of shares (1,062 units at $1,159.93) and exercised 1,062 shares at a strike of $312.36 (SEC Form 4)

      4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

      5/30/25 8:45:39 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Head of Process Analytics Keller Gerry was granted 88 shares, increasing direct ownership by 1,467% to 94 units (SEC Form 4)

      4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

      5/12/25 5:14:29 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Head of Eur & NA Market Orgs De La Guerroniere Marc was granted 186 shares (SEC Form 4)

      4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

      5/12/25 5:13:12 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Leadership Updates

    Live Leadership Updates

    See more
    • Mettler-Toledo International Inc. Announces Change to Board of Directors

      Columbus, OH, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Mettler-Toledo International Inc. (NYSE:MTD) announced today that Olivier Filliol informed the Company that he will not stand for re-election to the Board of Directors in May 2023. Mr. Filliol joined the Board in 2009 and served as President and CEO from January 1, 2008 through March 31, 2021.  Robert F. Spoerry, Chair of the Board, stated, "We want to sincerely thank Olivier for his many highly valuable contributions, and we are grateful for the unique expertise that he has brought to the Company. Olivier was instrumental in ensuring a successful CEO transition to Patrick Kaltenbach, which positions the Company well to continue its successf

      11/23/22 8:00:00 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Diggelmann Roland D bought $323,360 worth of shares (315 units at $1,026.54), increasing direct ownership by 350% to 405 units (SEC Form 4)

      4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

      11/15/23 9:00:20 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials